Breaking News

You are here » Indian-Commodity  :  Investment  :  Nilkamal to foray into foam manufacturing business

14-May2018

Nilkamal to foray into foam manufacturing business

Nilkamal has received an approval to venture into foam manufacturing business during the year 2018-2019. The board of directors at its meeting held on May 11, 2018 has approved for the same.

Nilkamal's principal activity is to manufacture injection moulded plastic products. It operates with three segments namely plastics, lifestyle furniture, furnishings & accessories and storage system & others.


Related News

View all news

Nettlinx to partner with two Japanese Investment firms

Nettlinx is set to partner with Japanese Investment firms - Takara Leben Company and Kuni Umi Asset Management Company. Both the Japanese companies plan to jointly invest up to 30% of equity in the SVGreen......

M&M acquires entire stake in Mahindra Automotive Mauritius

Mahindra & Mahindra (M&M) has acquired 100% stake in Mahindra Automotive Mauritius on November 06, 2018.M&M is the flagship company of the Mahindra Group, a multinational conglomerate......

Mphasis' arm acquires Stelligent Systems

Mphasis' wholly owned subsidiary -- Mphasis Corporation has acquired Stelligent Systems, LLC a US based, DevOps, continuous integration and continuous development, service provider in Amazon Web Services......

Top News

View all news

Aurobindo Pharma, TVS Motor and Lupin to see some action today

Aurobindo Pharma's wholly owned subsidiary -- Aurobindo Pharma USA Inc., has entered into an agreement to acquire a product under development and related assets from 'Advent Pharmaceuticals Pty, Australia,......

TVS Motor launches TVS Apache RTR 160 4V in Bangladesh

TVS Motor Company has launched the TVS Apache RTR 160 4V in Bangladesh. A testimony to the racing legacy of the TVS Apache RTR series, the TVS Apache RTR 160 4V will be the flagship offering of the brand......

Aurobindo Pharma's arm enters into agreement with Advent Pharma

Aurobindo Pharma's wholly owned subsidiary -- Aurobindo Pharma USA Inc. -- has entered into an agreement to acquire a product under development and related assets from Advent Pharmaceuticals Pty, Australia,......